Xeris Biopharma Holdings, Inc. ( XERS) - Stock Earnings
XERS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 11.1 million USD | 85.8 million USD |
| 2026Q1 | 2.2 million USD | 83.1 million USD |
| 2026Q2 | -31.1 million USD | 92.1 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
XERS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -62.3 million USD | 163.9 million USD |
| 2024 | -54.8 million USD | 203.1 million USD |
| 2025 | 554000 USD | 291.8 million USD |
| 2026 Est. | — | — |
XERS
Price: $8.60
52 week price:
Earnings Per Share: -0.10 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 485000
Market Capitalization: 1.5 billion